Table 2. P-values for fixed effects of dietary treatment and muscle effects

Fat % and fatty acid	Dietary treatment	Muscle	Dietary treatment×muscle	Fat % and fatty acid	Dietary treatment	Muscle	Dietary treatment×muscle
Fat%	0.0971	<0.0001	0.2711	C18:3 ω3	<0.0001	0.1592	0.4998
C8:0	0.0331	0.4203	0.2120	C20:0	0.1303	0.6489	0.4075
C10:0	0.2820	0.4636	0.6934	CLA 18:2c9t11	0.5352	0.7265	0.8650
C12:0	0.1641	0.5755	0.7388	C20:3 ω6	0.8001	0.0018	0.9618
C14:0	<0.0001	0.5032	0.2599	C20:4 ω6	0.0764	0.0002	0.7287
C14:1t ω5	0.4443	0.0456	0.8906	C22:4 ω6	0.2404	0.3254	0.8662
C14:1 ω5	<0.0001	0.8327	0.7381	C20:5 ω3	0.6077	0.4080	0.1886
C15:0	0.5572	0.7464	0.6932	C22:5 ω3	0.1837	0.6282	0.8063
C16:0	<0.0001	0.5365	0.2581	C22:6 ω3	0.4325	0.6537	0.6757
C16:1 ω7	<0.0001	0.1954	0.9095	Total trans	0.0190	0.1891	0.9613
C17:0	<0.0001	0.4236	0.9140	PUFA	0.0031	0.0048	0.7626
C17:1 ω5	0.0021	0.2852	0.4959	SFA	0.2343	0.7418	0.7130
C18:0	0.0010	0.9140	0.9076	ω6	0.0008	0.0049	0.8863
C18:1t1)	0.0111	0.2527	0.9183	ω3	0.6676	0.1932	0.2831
C18:1 ω9	0.2484	0.0118	0.7359	ω6:ω3	0.0162	0.2809	0.6844
C18:1d11 ω7	<0.0001	0.0108	0.3761	Total	0.8520	0.0049	0.9989
C18:2 ω6	<0.0001	0.0466	0.7945	Others	0.8520	0.0049	0.9989
C18:2t ω6	0.7615	0.3067	0.1824

Includes transvaccenic ω7, elaidic ω9, and ricinelaidic ω9 isomers.
PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids.